Occupe actuellement des postes chez Tocagen Inc, Amylin Pharmaceuticals LLC, AMN Healthcare Services Inc and DexCom Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Executive Vice President | Tocagen Inc | 1 février 2017 - |
Chief Financial Officer, Senior Vice President - Finance | Amylin Pharmaceuticals LLC | 1 mars 2006 - |
Independent Director | AMN Healthcare Services Inc | 12 décembre 2012 - |
Lead Independent Director | DexCom Inc | 1 novembre 2015 - |
Independent Director | Regulus Therapeutics Inc | 31 janvier 2013 - 1 avril 2018 |
Interim Chief Financial Officer | Biocept Inc | 21 août 2015 - 27 juillet 2016 |
Independent Director | DexCom Inc | 19 novembre 2014 - 1 novembre 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-01 | 2024-02-29 | A Achat |
500
+6.2%
56,9028 450 USD |
500 +6.2% | 56,90 | 28 450 USD | ||
2023-04-25 | 2023-04-21 | VP Vente planifiée |
1 458
-15.3%
88,78129 441 USD |
1 458 -15.3% | 88,78 | 129 441 USD | ||
2023-04-13 | 2023-04-11 | VP Vente planifiée |
1 053
-11.5%
84,6389 115 USD |
1 053 -11.5% | 84,63 | 89 115 USD | ||
2023-04-13 | 2023-04-11 | VP Vente planifiée |
4 989
-35.3%
84,29420 523 USD |
4 989 -35.3% | 84,29 | 420 523 USD | ||
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
41
-0.3%
569,5423 351 USD |
41 -0.3% | 569,54 | 23 351 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
2
-0.0%
567,351 135 USD |
2 -0.0% | 567,35 | 1 135 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
87
-0.7%
565,5149 200 USD |
87 -0.7% | 565,51 | 49 200 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
65
-0.5%
564,2436 675 USD |
65 -0.5% | 564,24 | 36 675 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
116
-0.9%
562,7965 283 USD |
116 -0.9% | 562,79 | 65 283 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
78
-0.6%
561,8543 824 USD |
78 -0.6% | 561,85 | 43 824 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
70
-0.5%
558,7839 115 USD |
70 -0.5% | 558,78 | 39 115 USD | |
2021-12-02 | 2021-12-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
41
-0.3%
556,8922 832 USD |
41 -0.3% | 556,89 | 22 832 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
40
-0.3%
634,0125 360 USD |
40 -0.3% | 634,01 | 25 360 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
40
-0.3%
631,2625 250 USD |
40 -0.3% | 631,26 | 25 250 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
42
-0.3%
629,3326 432 USD |
42 -0.3% | 629,33 | 26 432 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
76
-0.6%
628,4147 759 USD |
76 -0.6% | 628,41 | 47 759 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
56
-0.4%
627,7935 156 USD |
56 -0.4% | 627,79 | 35 156 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
7
-0.1%
626,054 382 USD |
7 -0.1% | 626,05 | 4 382 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
124
-0.9%
625,3277 540 USD |
124 -0.9% | 625,32 | 77 540 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
43
-0.3%
624,1026 836 USD |
43 -0.3% | 624,10 | 26 836 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
13
-0.1%
622,638 094 USD |
13 -0.1% | 622,63 | 8 094 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
14
-0.1%
619,328 670 USD |
14 -0.1% | 619,32 | 8 670 USD | |
2021-11-02 | 2021-11-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
45
-0.3%
615,1327 681 USD |
45 -0.3% | 615,13 | 27 681 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
1
-0.0%
551,58552 USD |
1 -0.0% | 551,58 | 552 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
51
-0.4%
547,0627 900 USD |
51 -0.4% | 547,06 | 27 900 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
181
-1.3%
544,3998 535 USD |
181 -1.3% | 544,39 | 98 535 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
126
-0.9%
543,1568 437 USD |
126 -0.9% | 543,15 | 68 437 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
88
-0.6%
540,9347 602 USD |
88 -0.6% | 540,93 | 47 602 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
6
-0.0%
539,103 235 USD |
6 -0.0% | 539,10 | 3 235 USD | |
2021-10-05 | 2021-10-01 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
47
-0.3%
538,0225 287 USD |
47 -0.3% | 538,02 | 25 287 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
301
-2.2%
342,93103 222 USD |
301 -2.2% | 342,93 | 103 222 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
428
-3.1%
341,79146 284 USD |
428 -3.1% | 341,79 | 146 284 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
117
-0.8%
340,2339 807 USD |
117 -0.8% | 340,23 | 39 807 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
139
-1.0%
337,7846 951 USD |
139 -1.0% | 337,78 | 46 951 USD | |
2020-11-18 | 2020-11-16 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
15
-0.1%
336,985 055 USD |
15 -0.1% | 336,98 | 5 055 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
208
-1.4%
398,2582 835 USD |
208 -1.4% | 398,25 | 82 835 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
375
-2.5%
397,41149 030 USD |
375 -2.5% | 397,41 | 149 030 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
255
-1.7%
396,51101 109 USD |
255 -1.7% | 396,51 | 101 109 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
120
-0.8%
395,0247 402 USD |
120 -0.8% | 395,02 | 47 402 USD | |
2020-10-19 | 2020-10-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
42
-0.3%
391,4816 442 USD |
42 -0.3% | 391,48 | 16 442 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
114
-0.7%
397,7545 344 USD |
114 -0.7% | 397,75 | 45 344 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
121
-0.8%
396,1747 936 USD |
121 -0.8% | 396,17 | 47 936 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
222
-1.4%
395,2887 753 USD |
222 -1.4% | 395,28 | 87 753 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
231
-1.5%
393,7390 951 USD |
231 -1.5% | 393,73 | 90 951 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
200
-1.2%
391,9578 390 USD |
200 -1.2% | 391,95 | 78 390 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
109
-0.7%
390,8642 604 USD |
109 -0.7% | 390,86 | 42 604 USD | |
2020-09-16 | 2020-09-14 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
3
-0.0%
386,211 159 USD |
3 -0.0% | 386,21 | 1 159 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
84
-0.6%
288,2624 214 USD |
84 -0.6% | 288,26 | 24 214 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
75
-0.6%
285,4821 411 USD |
75 -0.6% | 285,48 | 21 411 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
84
-0.6%
282,7723 753 USD |
84 -0.6% | 282,77 | 23 753 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
53
-0.4%
281,6114 925 USD |
53 -0.4% | 281,61 | 14 925 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
31
-0.2%
279,608 668 USD |
31 -0.2% | 279,60 | 8 668 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
64
-0.5%
277,4817 759 USD |
64 -0.5% | 277,48 | 17 759 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
114
-0.8%
275,5631 414 USD |
114 -0.8% | 275,56 | 31 414 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
155
-1.1%
274,8842 607 USD |
155 -1.1% | 274,88 | 42 607 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
81
-0.6%
272,8222 098 USD |
81 -0.6% | 272,82 | 22 098 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
152
-1.1%
271,5441 274 USD |
152 -1.1% | 271,54 | 41 274 USD | |
2020-03-04 | 2020-03-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
107
-0.8%
270,6328 957 USD |
107 -0.8% | 270,63 | 28 957 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
9
-0.1%
240,682 166 USD |
9 -0.1% | 240,68 | 2 166 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
166
-1.2%
238,8639 650 USD |
166 -1.2% | 238,86 | 39 650 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
524
-3.5%
238,05124 736 USD |
524 -3.5% | 238,05 | 124 736 USD | |
2020-02-05 | 2020-02-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
301
-2.0%
236,8471 290 USD |
301 -2.0% | 236,84 | 71 290 USD | |
2020-01-07 | 2020-01-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
133
-0.9%
218,9429 118 USD |
133 -0.9% | 218,94 | 29 118 USD | |
2020-01-07 | 2020-01-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
339
-2.2%
218,3974 035 USD |
339 -2.2% | 218,39 | 74 035 USD | |
2020-01-07 | 2020-01-03 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
528
-3.3%
217,61114 899 USD |
528 -3.3% | 217,61 | 114 899 USD | |
2019-05-29 | 2019-05-28 |
Tocagen Inc
(TOCA)
|
AP Achat planifié |
5 000
+49.8%
4,3021 475 USD |
5 000 +49.8% | 4,30 | 21 475 USD | |
2019-05-17 | 2019-05-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
400
-3.0%
122,7349 091 USD |
400 -3.0% | 122,73 | 49 091 USD | |
2019-05-17 | 2019-05-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
500
-3.6%
121,8860 939 USD |
500 -3.6% | 121,88 | 60 939 USD | |
2019-05-17 | 2019-05-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
100
-0.7%
118,6511 865 USD |
100 -0.7% | 118,65 | 11 865 USD | |
2019-04-17 | 2019-04-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
599
-4.1%
119,3671 497 USD |
599 -4.1% | 119,36 | 71 497 USD | |
2019-04-17 | 2019-04-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
301
-2.0%
118,8835 784 USD |
301 -2.0% | 118,88 | 35 784 USD | |
2019-04-17 | 2019-04-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
100
-0.7%
116,9611 696 USD |
100 -0.7% | 116,96 | 11 696 USD | |
2019-03-19 | 2019-03-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
100
-0.7%
151,9715 197 USD |
100 -0.7% | 151,97 | 15 197 USD | |
2019-03-19 | 2019-03-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
700
-4.4%
151,00105 698 USD |
700 -4.4% | 151,00 | 105 698 USD | |
2019-03-19 | 2019-03-15 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
200
-1.2%
146,9229 384 USD |
200 -1.2% | 146,92 | 29 384 USD |